Diagnosis Code C90.30
Information for Medical Professionals
The diagnosis code C90.30 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)
- 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC
- 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH CC
- 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 203.80 - Oth imno npl wo ach rmsn (approximate) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- Malignant immunoproliferative disease
- Multiple solitary plasmacytomas
- Non-Hodgkin's lymphoma of bone
- Plasma cell myeloma/plasmacytoma
- Solitary osseous myeloma
Index of Diseases and Injuries
References found for the code C90.30 in the Index of Diseases and Injuries:
- Inclusion Terms: Inclusion terms
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Solitary plasmacytoma WITH "With"
The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order. failed remission
- Solitary plasmacytoma NOS
- Solitary plasmacytoma WITH "With"
Information for Patients
Also called: Plasma-cell myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.
No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include
- Bone pain, often in the back or ribs
- Broken bones
- Weakness or fatigue
- Weight loss
- Frequent infections and fevers
- Feeling very thirsty
- Frequent urination
Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute
- Bence-Jones protein - quantitative (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Multiple myeloma (Medical Encyclopedia)
- Protein electrophoresis - serum (Medical Encyclopedia)
- Serum globulin electrophoresis (Medical Encyclopedia)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)